These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 26517354)

  • 101. Mutational status of KRAS and MMR genes in a series of colorectal carcinoma cases.
    Cionca FL; Dobre M; Dobrea CM; Iosif CI; Comănescu MV; Ardeleanu CM
    Rom J Morphol Embryol; 2018; 59(1):121-129. PubMed ID: 29940619
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Traditional Serrated Pathway-associated Colorectal Carcinoma: Morphologic Reappraisal of Serrated Morphology, Tumor Budding, and Identification of Frequent PTEN Alterations.
    Tsai JH; Jeng YM; Yuan CT; Lin YL; Cheng ML; Liau JY
    Am J Surg Pathol; 2019 Aug; 43(8):1042-1051. PubMed ID: 31094930
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The ATOM-Seq sequence capture panel can accurately predict microsatellite instability status in formalin-fixed tumour samples, alongside routine gene mutation testing.
    Srihar K; Gusnanto A; Richman SD; West NP; Galvin L; Bottomley D; Hemmings G; Glover A; Natarajan S; Miller R; Arif S; Rossington H; Dunwell TL; Dailey SC; Fontarum G; George A; Wu W; Quirke P; Wood HM
    Sci Rep; 2024 Sep; 14(1):21870. PubMed ID: 39300198
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Colorectal oncogenesis].
    Laurent-Puig P; Agostini J; Maley K
    Bull Cancer; 2010 Nov; 97(11):1311-21. PubMed ID: 21115420
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.
    Sahnane N; Magnoli F; Bernasconi B; Tibiletti MG; Romualdi C; Pedroni M; Ponz de Leon M; Magnani G; Reggiani-Bonetti L; Bertario L; Signoroni S; Capella C; Sessa F; Furlan D;
    Clin Epigenetics; 2015; 7():131. PubMed ID: 26697123
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
    Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
    J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Chr20q Amplification Defines a Distinct Molecular Subtype of Microsatellite Stable Colorectal Cancer.
    Zhang B; Yao K; Zhou E; Zhang L; Cheng C
    Cancer Res; 2021 Apr; 81(8):1977-1987. PubMed ID: 33619118
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
    Chakrabarty S; Varghese VK; Sahu P; Jayaram P; Shivakumar BM; Pai CG; Satyamoorthy K
    Br J Cancer; 2017 Jun; 117(1):136-143. PubMed ID: 28524162
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability.
    Thorstensen L; Lind GE; Løvig T; Diep CB; Meling GI; Rognum TO; Lothe RA
    Neoplasia; 2005 Feb; 7(2):99-108. PubMed ID: 15802015
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Cell line models for drug discovery in PIK3CA-mutated colorectal cancers.
    Voutsadakis IA
    Med Oncol; 2022 May; 39(5):89. PubMed ID: 35568775
    [TBL] [Abstract][Full Text] [Related]  

  • 112. BAT26 Only Microsatellite Instability with High Tumor Mutation Burden-A Rare Entity Associated with PTEN Protein Loss and High PD-L1 Expression.
    Kang SY; Kim DG; Kim KM
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142641
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Subtyping of microsatellite instability-high colorectal cancer.
    Hu W; Yang Y; Qi L; Chen J; Ge W; Zheng S
    Cell Commun Signal; 2019 Jul; 17(1):79. PubMed ID: 31331345
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation Sequencing.
    Kim JE; Chun SM; Hong YS; Kim KP; Kim SY; Kim J; Sung CO; Cho EJ; Kim TW; Jang SJ
    J Mol Diagn; 2019 Mar; 21(2):241-250. PubMed ID: 30389464
    [TBL] [Abstract][Full Text] [Related]  

  • 115. TP53 mutations in colorectal cancer from Tunisia: relationships with site of tumor origin, microsatellite instability and KRAS mutations.
    Aissi S; Buisine MP; Zerimech F; Kourda N; Moussa A; Manai M; Porchet N
    Mol Biol Rep; 2014 Mar; 41(3):1807-13. PubMed ID: 24443225
    [TBL] [Abstract][Full Text] [Related]  

  • 116. A functional assay for mutations in tumor suppressor genes caused by mismatch repair deficiency.
    Ji HP; King MC
    Hum Mol Genet; 2001 Nov; 10(24):2737-43. PubMed ID: 11734538
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Concurrent inactivating mutations and expression losses of RGS2, HNF1A, and CAPN12 candidate tumor suppressor genes in colon cancers.
    Kim JW; Moon SW; Mo HY; Son HJ; Choi EJ; Yoo NJ; Ann CH; Lee SH
    Pathol Res Pract; 2023 Jan; 241():154288. PubMed ID: 36566600
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers.
    Liu F; Zhong F; Wu H; Che K; Shi J; Wu N; Fu Y; Wang Y; Hu J; Qian X; Fan X; Wang W; Wei J
    Oncologist; 2023 Mar; 28(3):e136-e144. PubMed ID: 36724040
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Mutational and expressional alterations of ZMPSTE24, DNA damage response-related gene, in gastric and colorectal cancers.
    Lee JH; Yoo NJ; Kim MS; An CH; Lee SH
    Pathol Res Pract; 2016 Dec; 212(12):1113-1118. PubMed ID: 27729169
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Targeted next generation sequencing of MLH1-deficient, MLH1 promoter hypermethylated, and BRAF/RAS-wild-type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions.
    Vaňková B; Vaněček T; Ptáková N; Hájková V; Dušek M; Michal M; Švajdler P; Daum O; Daumová M; Michal M; Mezencev R; Švajdler M
    Genes Chromosomes Cancer; 2020 Oct; 59(10):562-568. PubMed ID: 32427409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.